Literature DB >> 12416871

Pharmacokinetic disposition of subcutaneously administered enrofloxacin in goats.

S Ramesh1, G S Rao, J K Malik.   

Abstract

The pharmacokinetic disposition of enrofloxacin was studied in goats after subcutaneous (s.c.) administration at a single dose of 7.5 mg/kg body weight. Blood samples were drawn from a jugular vein into heparinized tubes at predetermined time intervals after administration of the drug and the plasma was separated by centrifugation. The concentrations of enrofloxacin in the plasma were determined by a microbiological assay using Escherichia coli as the test organism. The plasma concentration-time data were analysed by non-compartmental methods. Enrofloxacin was rapidly absorbed, an appreciable concentration of the drug (0.30 +/- 0.13 microg/ml) being present in the plasma by 5 min after s.c. administration. The maximum plasma concentration of enrofloxacin and the time to reach that maximum were 2.91 +/- 0.39 microg/ml and 2.9 +/- 0.51 h. respectively. A detectable concentration of enrofloxacin persisted in the plasma for 12 h. The elimination half-life and mean residence time of enrofloxacin were 2.84 +/- 0.57 and 5.74 +/- 0.28 h, respectively. It is suggested that enrofloxacin given subcutaneously may be useful in the treatment of susceptible bacterial infections in goats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12416871     DOI: 10.1023/a:1020295632767

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  17 in total

1.  Pharmacokinetics and dosage regimen of enrofloxacin in buffalo bulls after intramuscular administration.

Authors:  H K Verma; G R Pangawkar; R K Chaudhary; A K Srivastava
Journal:  Vet Res Commun       Date:  1999-12       Impact factor: 2.459

2.  Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration.

Authors:  L Kaartinen; S Panu; S Pyörälä
Journal:  Equine Vet J       Date:  1997-09       Impact factor: 2.888

3.  Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows.

Authors:  L Kaartinen; M Salonen; L Alli; S Pyörälä
Journal:  J Vet Pharmacol Ther       Date:  1995-10       Impact factor: 1.786

4.  Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs.

Authors:  K Küng; J L Riond; M Wanner
Journal:  J Vet Pharmacol Ther       Date:  1993-12       Impact factor: 1.786

5.  Outline of details for microbiological assays of antibiotics: second revision.

Authors:  B Arret; D P Johnson; A Kirshbaum
Journal:  J Pharm Sci       Date:  1971-11       Impact factor: 3.534

6.  Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.

Authors:  A Anadón; M R Martínez-Larrañaga; M J Díaz; M L Fernández-Cruz; M A Martínez; M T Frejo; M Martínez; J Iturbe; M Tafur
Journal:  Am J Vet Res       Date:  1999-11       Impact factor: 1.156

7.  Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses.

Authors:  S Giguère; R W Sweeney; M Bélanger
Journal:  Am J Vet Res       Date:  1996-07       Impact factor: 1.156

8.  Effect of water deprivation on the disposition kinetics of enrofloxacin in camels.

Authors:  R Gavrielli; R Yagil; G Ziv; C V Creveld; A Glickman
Journal:  J Vet Pharmacol Ther       Date:  1995-10       Impact factor: 1.786

9.  Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis.

Authors:  G L Drusano; D E Johnson; M Rosen; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

10.  In vitro efficacy of cefquinome (INN) and other anti-infective drugs against bovine bacterial isolates from Belgium, France, Germany, The Netherlands, and the United Kingdom.

Authors:  A Böttner; P Schmid; R Humke
Journal:  Zentralbl Veterinarmed B       Date:  1995-08
View more
  1 in total

1.  Pharmacokinetic behaviour of enrofloxacin and its metabolite ciprofloxacin after subcutaneous administration in cattle.

Authors:  J J de Lucas; M I San Andrés; F González; R Froyman; C Rodríguez
Journal:  Vet Res Commun       Date:  2008-02-05       Impact factor: 2.459

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.